This did not present a risk in the researchers sample because they excluded people with body-mass indices (BMIs) lower than 23 (the World Health Organization considers BMIs 18.5 24.9 normal), and most study participants had a BMI of 30 or more (classified as obese)
The studies included in the analysis demonstrated variability in terms of their study design, the GLP-1 agonists investigated, the dosages administered, and the outcome measures assessed
SUPER SIMPLE GLP-1 DIET MEAL PLAN COOKBOOK FOR BEGINNERS 2025: Delicious & Easy High Protein Recipes to Optimize Satiety, Weight Management, Insulin and Metabolism with Targeted Macronutrient Synergy [Austin, Sapphire] on Amazon.com
If you have specific aesthetic goals or are curious about other treatments, be sure to discuss them with Melanie during your consultation
As in the case of lung diseases [923,928,931], also for cardiovascular diseases, GWAS studies were conducted to identify possible risk factors which might influence the disease outcome [994,995,996]
doi: 10.1016/j.bone.2015.08.006